Cargando…
Hif-1α Deletion May Lead to Adverse Treatment Effect in a Mouse Model of MLL-AF9-Driven AML
Relapse of acute myeloid leukemia (AML) remains a significant clinical challenge due to limited therapeutic options and poor prognosis. Leukemic stem cells (LSCs) are the cellular units responsible for relapse in AML, and strategies that target LSCs are thus critical. One proposed potential strategy...
Autores principales: | Velasco-Hernandez, Talia, Soneji, Shamit, Hidalgo, Isabel, Erlandsson, Eva, Cammenga, Jörg, Bryder, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6335588/ https://www.ncbi.nlm.nih.gov/pubmed/30595549 http://dx.doi.org/10.1016/j.stemcr.2018.11.023 |
Ejemplares similares
-
Potential Pitfalls of the Mx1-Cre System: Implications for Experimental Modeling of Normal and Malignant Hematopoiesis
por: Velasco-Hernandez, Talia, et al.
Publicado: (2016) -
Protocol to establish a stable MLL-AF9_AML mouse model
por: Lu, Jun, et al.
Publicado: (2022) -
Immunoediting is not a primary transformation event in a murine model of MLL-ENL AML
por: Dudenhöffer-Pfeifer, Monika, et al.
Publicado: (2018) -
SCExV: a webtool for the analysis and visualisation of single cell qRT-PCR data
por: Lang, Stefan, et al.
Publicado: (2015) -
Expression of MLL-AF4 or AF4-MLL fusions does not impact the efficiency of DNA damage repair
por: Castaño, Julio, et al.
Publicado: (2016)